137 completed, 31 unknown, 21 recruiting, 16 terminated. 225 Phase 2, 56 Phase 3, 45 Phase 1.
Follow control: new trials by email Literature Review of control trials Research Report on control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opt-IVF for Personalized Medicine for Normal Responders Opt-IVF, control - Ivf | Phase 1 / Phase 2 | Active not recruiting | Urmila DIwekar | 100 | 2026-10-15 | 2026-11-03 |
| dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy dMD-002, Control - Prostate Cancer | Phase 1 / Phase 2 | Not yet recruiting | Mochida Medical USA, Inc. | 30 | 2026-08-01 | 2026-05-15 |
| A Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of APC101 in Patients With Postherpetic Neuralgia. APC101, Control - PHN - Post-Herpetic Neuritis | Phase 2 / Phase 3 | Not yet recruiting | Andros Pharmaceuticals Co., Ltd. | 333 | 2026-08-01 | 2026-05-20 |
| Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma. Dried chicory roots, Placebo - Melanoma (Skin) Stage IV, Melanoma (Skin Cancer) | Phase 2 | Recruiting | Radboud University Medical Center | 70 | 2026-07-31 | 2026-07-27 |
| A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss SPI-1005 200mg, SPI-1005 400mg, Placebo - Noise Induced Hearing Loss | Phase 2 | Withdrawn | Sound Pharmaceuticals, Incorporated | 2026-06-01 | 2026-06-03 | |
| Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel Sesame Oil, Aloe vera gel, Control - Cancer, Chemotherapy | Phase 2 | Not yet recruiting | University of Basrah | 190 | 2026-05-11 | 2026-04-28 |
| Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis Luspatercept, Control - Luspatercept, Poor Erythroid Engraftment | Phase 2 / Phase 3 | Not yet recruiting | Nanfang Hospital, Southern Medical University | 196 | 2026-05-01 | 2026-04-20 |
| Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids C. cicadae, Control - Amyotrophic Lateral Sclerosis | Phase 2 | Not yet recruiting | The Third Xiangya Hospital of Central South University | 84 | 2026-04-01 | 2026-05-20 |
| A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract 0.4% ZOC2017217, Control - Age Related Cataracts | Phase 2 | Active not recruiting | Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. | 8 | 2026-02-10 | 2026-08-11 |
| Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression Ketamine hydrochloride, Minimally Enhanced Usual Care, Brief narrative intervention - Chronic Low Back Pain, Depression | Phase 2 | Recruiting | VA Office of Research and Development | 44 | 2025-12-03 | 2025-12-18 |
| An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera Opt-IVF, Control - Infertility (IVF Patients) | Phase 1 / Phase 2 | Recruiting | Urmila DIwekar | 200 | 2025-09-23 | 2025-09-29 |
| Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases Pharmacoscopy 1.0, Control - Brain Metastases, Brain Metastases, Adult | Phase 2 | Recruiting | University of Zurich | 102 | 2025-09-12 | 2026-06-29 |
| Nurse-Led Elderly Sleep Intervention Otago programme, Otago programme + Cognifit, Control - Sleep, Gerontology | Phase 1 / Phase 2 | Completed | University of Castilla-La Mancha | 66 | 2025-09-01 | 2026-05-22 |
| Healthy Ageing: a Feasibility Study to Evaluate Digitally-enabled Ways to Support Healthy Ageing Smart devices with Personalised data feedback and habit coaching, Smart devices with data feedback, Control - Frailty, Older Adults (65 Years and Older) | Phase 2 | Active not recruiting | Imperial College London | 30 | 2025-07-28 | 2026-03-25 |
| Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin Cilastatin Sodium, Placebo-Saline - Acute Kidney Injury | Phase 2 | Recruiting | Matthew James | 698 | 2025-07-16 | 2026-11-13 |
| Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients phage therapy, control - Urinary Tract Infection, Recurrent | Phase 1 / Phase 2 | Recruiting | University of California, San Diego | 32 | 2025-06-15 | 2025-08-14 |
| ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty Corneal Donor Tissue with Cross Linking, Corneal Donor Tissue without Cross Linking - Corneal Transplant Failure | Phase 2 | Recruiting | Massachusetts Eye and Ear Infirmary | 96 | 2025-04-01 | 2026-09-21 |
| A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol ChAd-triCoV/Mac, Control - COVID-19 Infection | Phase 2 | Recruiting | McMaster University | 350 | 2025-03-25 | 2026-01-26 |
| Response to Exercise and Nitric Oxide in PAD Supervised Treadmill Exercise, Attention Control, Nitrate-Rich Beetroot Juice + supervised exercise therapy - Peripheral Artery Disease, Exercise | Phase 2 | Recruiting | Northwestern University | 200 | 2025-01-23 | 2026-07-27 |
| Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury control, propranolol, Carvedilol - TBI Traumatic Brain Injury | Phase 1 / Phase 2 | Recruiting | Mansoura University | 100 | 2025-01-20 | 2025-04-02 |
Showing 20 of 225. Sign in to see all of them.
COVID-19 (9) · Diabetes Mellitus, Type 2 (7) · Diabetes Mellitus (6) · Motor Activity (6) · Burns (4) · Cystic Fibrosis (4) · Heart Failure (4) · Inflammation (4) · Myocardial Infarction (4) · Pain, Postoperative (4) · Peripheral Arterial Disease (4) · Pneumonia (4) · Spinal Cord Injuries (4) · Acute Kidney Injury (3) · Alzheimer Disease (3)
Johns Hopkins University (5) · Royan Institute (5) · Dompé Farmaceutici S.p.A (4) · The University of Texas Medical Branch, Galveston (4) · VA Office of Research and Development (3) · Assiut University (2) · CHU de Quebec-Universite Laval (2) · Charite University, Berlin, Germany (2) · Islamic Azad University, Sanandaj (2) · Kasiak Research Pvt. Ltd. (2) · Mesoblast, Ltd. (2) · National Cancer Institute, Egypt (2) · National Nutrition and Food Technology Institute (2) · Nivalis Therapeutics, Inc. (2) · Shenzhen Ausa Pharmed Co.,Ltd (2)
United States (86) · Canada (15) · China (13) · Spain (12) · Egypt (11) · Brazil (10) · Germany (10) · United Kingdom (10) · Iran (9) · Italy (8) · France (7) · India (5) · Mexico (5) · Sweden (4) · Australia (3)
David N Herndon, MD (4) · Ashraf Moini, MD (2) · Ehab H Shaker, MD (2) · Hamid Gourabi, PhD (2) · Hossein Baharvand, PhD (2) · Julio J Ochoa, Ph.D. (2) · Marzieh Shiva, MD (2) · Paul C Cremer, M. D. (2) · Roger Brown (2) · Santiago A Garcia, MD (2) · A Bhansali (1) · Adriana Andrade, MD, MPH (1) · Aisha K Yousafzai, PhD (1)
PMID 33754144, PMID 10439740, PMID 10686270, PMID 11032280, PMID 11425500, PMID 11595691, PMID 11772567, PMID 12088953, PMID 12529557, PMID 12960545, PMID 15037681, PMID 15125017, PMID 15781453, PMID 15863172, PMID 15922087, PMID 16108461, PMID 16174242, PMID 16473126, PMID 16616662, PMID 16901646, PMID 17297830, PMID 1742815, PMID 17655918, PMID 17954800, PMID 18385498, PMID 18407790, PMID 18801868, PMID 19128879, PMID 19416339, PMID 19422355, PMID 19425235, PMID 19559969, PMID 19618698, PMID 19640281, PMID 19734776, PMID 19794023, PMID 19826112, PMID 19944358, PMID 19944914, PMID 20418657, PMID 20424252, PMID 20495811, PMID 20556751, PMID 20622770, PMID 20881067, PMID 21218740, PMID 21410418, PMID 21452051, PMID 21471870, PMID 21530398
2009 (3), 2018 (2), 2023 (2), 5KL2TR001109-05 (1), IK2CX002646-01A2 (1), K07CA132916 (1), P01HL103455 (1), P50GM060338 (1), R00NR016484 (1), R01CA134903 (1), R01DA012403 (1), R01DA013496 (1), R01DA023877 (1), R01DK069861 (1), R01HL042814 (1)